US SB4232 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on May 1 2024 - 25% progression
Action: 2024-05-01 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

FAUCI Act Fixing Administrations Unethical Corrupt Influence Act

Sponsors

Sen. J.D. Vance [R-OH]

History

DateChamberAction
2024-05-01SenateRead twice and referred to the Committee on the Judiciary.

US Congress State Sources


Bill Comments

feedback